Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.
Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.
Jan Willem Popma
Director, Ace Pharmaceuticals BV
Talk to the deal team
JOST-Werke AG has sold Edbro to Endless Enact
JOST-Werke AG (JOST) has sold its UK hydraulics subsidiary, Edbro, to Endless Enact.Learn more
Palmatum has raised capital to build a major commercial facility in Montreal
The founder of Project Palmatum has raised capital in order to build and operate Montreal’s major and most innovative commercial B2C trade floor – 150,000 sqft dedicated to garden and home interior.Learn more
Grupo BC has acquired Lexer
The owners of Lexer have sold the company to Grupo BC. With this acquisition, Grupo BC consolidates its position as provider of critical processes to the main Spanish financial institutions and offers the potential for Lexer to expand in Latin America while continuing to consolidate the Spanish debt collection sector.Learn more